Clin Chem. 1991 Dec;37(12):2143-5.

Urinary excretion of free toluenediamines in a patient with polyurethane-covered breast implants.

·         Chan SC,

·         Birdsell DC,

·         Gradeen CY.

Department of Laboratory Medicine, Foothills Hospital, Calgary, Alberta, Canada.

We report the detection of free 2,4-toluenediamine in urine of a patient implanted with polyurethane-covered breast implants. Samples were collected on several dates, ranging from 21 days to seven months after the insertion of the implants, and these samples all showed the presence of free 2,4-toluenediamine at a concentration of about 1 micrograms/L. The chemical was not found in a urine sample collected before implantation. This finding is important for risk assessment of cancer in patients with this type of breast implant because the chemical is a suspected carcinogen. Free 2,6-toluenediamine, an isomer, was also found in all samples from this patient.

PMID: 1662561 [PubMed - indexed for MEDLINE]

Alternative Implants

The information on this website is presented for educational purposes by the Human Adjuvant Disease Corp.